Mark Eisner is EVP, Chief Medical Officer of FibroGen, Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Jul 24 | VIR Vir Biotechnology | Common Stock | Grant | Acquire A | No | No | 0 | 75,000 | 0.00 | 75,000 |
15 Jul 24 | VIR Vir Biotechnology | Stock Option (Right to Buy) Common Stock | Grant | Acquire A | No | No | 9.37 | 150,000 | 1.41 mm | 150,000 |
6 Sep 23 | FGEN FibroGen | Common Stock | Payment of exercise | Dispose F | No | No | 0.9631 | 1,860 | 1.79 k | 159,917 |
1 Sep 23 | FGEN FibroGen | Common Stock | Payment of exercise | Dispose F | No | No | 1.06 | 1,085 | 1.15 k | 161,777 |
7 Jun 23 | FGEN FibroGen | Common Stock | Sell | Dispose S | No | No | 17.038 | 2,042 | 34.79 k | 162,862 |